BioAge Labs, Inc.
BIOA
$10.60
$0.171.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.10M | -22.25M | -25.94M | -20.17M | -21.56M |
| Total Depreciation and Amortization | 70.00K | 63.00K | 69.00K | 49.00K | 58.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.95M | 4.14M | 1.36M | 2.85M | 3.32M |
| Change in Net Operating Assets | 2.82M | -5.99M | -3.74M | 1.23M | -1.79M |
| Cash from Operations | -19.26M | -24.05M | -28.25M | -16.04M | -19.97M |
| Capital Expenditure | -328.00K | -26.00K | -112.00K | -22.00K | -159.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -164.19M | -46.73M | -14.32M | 12.86M | -15.48M |
| Cash from Investing | -164.51M | -46.75M | -14.43M | 12.84M | -15.64M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -500.00K | -1.50M | -1.50M | -1.50M | -1.50M |
| Issuance of Common Stock | 17.33M | 126.02M | 17.87M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -859.00K | -807.00K | -356.00K | -44.00K | -- |
| Cash from Financing | 15.97M | 123.72M | 16.01M | -1.54M | -1.50M |
| Foreign Exchange rate Adjustments | -5.00K | -27.00K | -19.00K | -10.00K | -46.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -167.81M | 52.89M | -26.69M | -4.76M | -37.16M |